JAMI GIBSON: Open Payments
NPI 1376889964 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,928 in 83 payments from 16 companies in 2025. Trend: 2023 $871 · 2024 $1,265 · 2025 $1,928
Food & beverage: $1,928
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $465 |
| ABBVIE INC. | 19 | $463 |
| Novo Nordisk Inc | 28 | $458 |
| Mayne Pharma Commercial LLC | 1 | $89 |
| Exact Sciences Corporation | 4 | $77 |
| Edwards Lifesciences Corporation | 2 | $66 |
| Lilly USA, LLC | 4 | $65 |
| Phathom Pharmaceuticals, Inc. | 5 | $61 |
| PFIZER INC. | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $28 |
Products named: BREZTRI, Ozempic, QULIPTA, UBRELVY, AIRSUPRA, Rybelsus, BIJUVA, SAPIEN 3 Ultra RESILIA.
Industry payments across OH — which companies pay providers there.
